cholestatic liver diseases

source: pixabay.com

Phase 1 Trial for Primary Biliary Cholangitis Therapy Produces Promising Results

Post author:Trudy Horsting
Post published:January 7, 2022
Post category:Primary Biliary Cholangitis Primary sclerosing cholangitis

Albireo Pharma Inc. has just announced the results from their Phase 1 clinical trial for A3907, an ASBT inhibitor. The study produced positive results, achieving its primary and secondary endpoints. Researchers…

We believe rare disease patients are people, not a diagnosis. Through education, awareness and some humor, we help patients, caregivers and support persons by providing relevant and often inspirational news and stories.

Our goals are to share stories, cultivate strong community, provide the latest medical findings, connect people and pioneer production of patient worthy information. Help us attain these goals by telling us a little bit about yourself!

Let’s Work Together!

Keep Up to Date

Learn More